LUND, Sweden--(BUSINESS WIRE)--Regulatory News:
BioInvent International (OMXS: BINV) announces that its partnership with a leading U.S. biotechnology company advances to next phase. The collaboration aims to discover novel therapeutic antibodies to be incorporated into the U.S. company’s CAR-T programs.
Help employers find you! Check out all the jobs and post your resume.
BioInvent International (OMXS: BINV) announces that its partnership with a leading U.S. biotechnology company advances to next phase. The collaboration aims to discover novel therapeutic antibodies to be incorporated into the U.S. company’s CAR-T programs.
Help employers find you! Check out all the jobs and post your resume.
